Synthesis and immune response of non-native isomers of vascular endothelial growth factor

Biochemistry

Volumn 49, Issue 31, 2010, Pages 6550-6556

  Jiang, Chuantao ^a   Xiong, Wei ^a   Lu, Bao Yuan ^a   Gonda, Matthew A ^b   Chang, Jui Yoa ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b IsoVax Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE-RELATED MACULAR DEGENERATION; CANCER IMMUNOTHERAPY; EFFECTIVE THERAPY; IMMUNE RESPONSE; IMMUNE TOLERANCES; IMMUNOGENICITY; IMMUNOGENS; NATIVE PROTEINS; NON-NATIVE; OXIDATIVE FOLDING; UNDERLYING MECHANISM; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF ISOFORMS;

ANTIBODIES; BIOACTIVITY; PEPTIDES; SELF ASSEMBLY;

ISOMERS;

ALANINE; CYSTEINE; DISULFIDE; MONOCLONAL ANTIBODY; VACCINE; VASCULOTROPIN;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ARTICLE; CANCER IMMUNOTHERAPY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS REACTION; IMMUNE RESPONSE; IMMUNOGENICITY; ISOMER; MALE; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; RETINA MACULA AGE RELATED DEGENERATION; SYNTHESIS;

ANIMALS; ANTIBODY FORMATION; CANCER VACCINES; IMMUNOTHERAPY; MACULAR DEGENERATION; MICE; NEOPLASMS; PROTEIN ENGINEERING; PROTEIN ISOFORMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 77955238515     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi100815n     Document Type: Article

References (36)

1. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen Science 246, 1306-1309
2. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., and Dvorak, H. F. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid Science 219, 983-985
3. Ferrara, N. (2004) Vascular endothelial growth factor: basic science and clinical progress Endocr. Rev. 25, 581-611 (Pubitemid 39099316)
4. Ribatti, D. (2005) The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review Br. J. Haematol. 128, 303-309
5. Folkman, J. (1971) Tumor angiogenesis: therapeutic implications N. Engl. J. Med. 285, 1182-1186
6. Folkman, J. (2007) Angiogenesis: an organizing principle for drug discovery? Nat. Rev. Drug Discovery 6, 273-286 (Pubitemid 46505878)
7. Ferrara, N. and Kerbel, R. S. (2005) Angiogenesis as a therapeutic target Nature 438, 967-974
8. Ferrara, N. (2002) VEGF and the quest for tumour angiogenesis factors Nat. Rev. Cancer 2, 795-803
9. Sandler, A., Gray, R., Perry, M. C., Brahmer, J., Schiller, J. H., Dowlati, A., Lilenbaum, R., and Johnson, D. H. (2006) Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer N. Engl. J. Med. 355, 2542-2550 (Pubitemid 44917502)
10. Sandler, A. (2007) Bevacizumab in non small cell lung cancer Clin. Cancer Res. 13, s4613-4616
11. Sane, D. C., Anton, L., and Brosnihan, K. B. (2004) Angiogenic growth factors and hypertension Angiogenesis 7, 193-201
12. Eremina, V., Jefferson, J. A., Kowalewska, J., Hochster, H., Haas, M., Weisstuch, J., Richardson, C., Kopp, J. B., Kabir, M. G., Backx, P. H., Gerber, H. P., Ferrara, N., Barisoni, L., Alpers, C. E., and Quaggin, S. E. (2008) VEGF inhibition and renal thrombotic microangiopathy N. Engl. J. Med. 358, 1129-1136 (Pubitemid 351398487)
13. Scappaticci, F. A., Skillings, J. R., Holden, S. N., Gerber, H. P., Miller, K., Kabbinavar, F., Bergsland, E., Ngai, J., Holmgren, E., Wang, J., and Hurwitz, H. (2007) Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab J. Natl. Cancer Inst. 99, 1232-1239
14. Chang, J.-Y. (1999) Denatured states of tick anticoagulant peptide. Compositional analysis of unfolded scrambled isomers J. Biol. Chem. 274, 123-128
15. Chang, J.-Y. and Li, L. (2001) The structure of denatured alpha-lactalbumin elucidated by the technique of disulfide scrambling: fractionation of conformational isomers of alpha-lactalbumin J. Biol. Chem. 276, 9705-9712
16. Chang, J.-Y. (2009) Conformational isomers of denatured and unfolded proteins: methods of production and applications Protein J. 28, 44-56
17. Chang, J.-Y. (1995) The properties of scrambled hirudins J. Biol. Chem. 270, 25661-25666
18. Salamanca, S., Virtudes, V., Vendrell, J., Li, L., Aviles, F. X., and Chang, J.-Y. (2002) The unfolding pathway of leech carboxypeptidase inhibitor J. Biol. Chem. 277, 17538-17543
19. Min, C.-Y., Qiao, Z.-S., and Feng, Y.-M. (2001) Unfolding of human proinsulin. Intermediates and possible role of its C-peptide in folding/unfolding Eur. J. Biochem. 271, 1737-1747
20. Muller, Y. A., Li, B., Christinger, H. W., Wells, J. A., Cunningham, B. C., and De Vos, A. M. (1997) Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site Proc. Natl. Acad. Sci. U.S.A. 94, 7192-7197
21. Christinger, H. W. and De Vos, A. M. 1996, Crystallization of the receptor binding domain of vascular endothelial growth factor Proteins 26, 353-357
22. Ebos, J. M., Lee, C. R., Cruz-Munoz, W., Bjarnason, G. A., Christensen, J. G., and Kerbel, R. S. (2009) Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis Cancer Cell 15, 232-239
23. Kopetz, S., Hoff, P. M., Morris, J. S., Wolff, R. A., Eng, C., Glover, K. Y., Adinin, R., Overman, M. J., Valero, V., Wen, S., Lieu, C., Yan, S., Tran, H. T., Ellis, L. M., Abbruzzese, J. L., and Heymach, J. V. (2010) Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance J. Clin. Oncol. 28, 453-459
24. Arias-Moreno, X., Arolas, L. L., Aviles, F. X., Sancho, J., and Ventura, S. (2008) Scrambled isomers as key intermediates in the oxidative folding of ligand binding module 5 of the low density lipoprotein receptor J. Biol. Chem. 283, 13627-13637
25. Chang, J.-Y. (1997) A two-stage mechanism for the reductive unfolding of disulfide-containing proteins J. Biol. Chem. 272, 69-75
26. Schlungger, M. P. and Gruetter, M. G. (1993) Refined crystal structure of human transforming growth factor 2 at 1.95 Å resolution J. Mol. Biol. 231, 445-458
27. Craik, D. J., Daly, N. L., Bond, T., and Waine, C. (1999) Plant cyclotides: a unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif J. Mol. Biol. 294, 1327-1336
28. Colgrave, M. L. and Craik, D. J. (2004) Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot Biochemistry 43, 5965-5975
29. Chang, J.-Y., Lu, B. Y., and Lai, P. H. (2006) Oxidative folding of hirudin in human serum Biochem. J. 394, 249-257
30. Kadokura, H., Katzen, F., and Beckwith, J. (2003) Protein disulfide bond formation in prokaryotes Annu. Rev. Biochem. 72, 111-135
31. Freedman, R. B., Hirst, T. R., and Tuite, M. F. (1994) Protein disulfide isomerase: building bridges in protein folding Trends Biochem. Sci. 19, 331-336
32. Wilkinson, B. and Gilbert, H. F. (2004) Protein disulfide isomerase Biochim. Biophys. Acta 1699, 35-44
33. Williams, R. H., Maggiore, J. A., Reynolds, R. D., and Helgason, C. M. (2001) Novel approach for the determination of the redox status of homocysteine and other aminothiols in plasma from healthy subjects and patients with Ischemic stroke Clin. Chem. 47, 1031-1039
34. Chang, J.-Y., Lu, B.-Y., and Li, L. (2005) Conformational impurity of disulfide proteins: detection, quantification and properties Anal. Biochem. 342, 78-85
35. Atassi, M. Z. and Casali, P. (2008) Molecular mechanisms of autoimmunity Autoimmunity 41, 123-132
36. Elliott, S., Chang, D., Delorme, E., Dunn, C., Egrie, J., Giffin, J., Lorenzini, T., Talbot, C., and Hesterberg, L. (1996) Isolation and characterization of conformation sensitive anti-erythropoietin monoclonal antibodies: effect of disulfide bonds and carbohydrate on recombinant human erythropoietin structure Blood 87, 2714-2722